Skip to main content

Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).

Publication ,  Journal Article
Sharma, A; Kaiser, PK; Tadayoni, R; Holz, FG; Nicholson, L; Vazquez-Alfageme, C; Sivaprasad, S; Wakabayashi, T; Woo, SJ; Sarraf, D; Kumar, N ...
Published in: Eye (Lond)
December 2024

Duke Scholars

Published In

Eye (Lond)

DOI

EISSN

1476-5454

Publication Date

December 2024

Volume

38

Issue

17

Start / End Page

3392 / 3395

Location

England

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 3204 Immunology
  • 1113 Opthalmology and Optometry
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sharma, A., Kaiser, P. K., Tadayoni, R., Holz, F. G., Nicholson, L., Vazquez-Alfageme, C., … International Retina Biosimilar Study Group (Inter BIOS Group). (2024). Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond), 38(17), 3392–3395. https://doi.org/10.1038/s41433-024-03284-x
Sharma, Ashish, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, et al. “Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).Eye (Lond) 38, no. 17 (December 2024): 3392–95. https://doi.org/10.1038/s41433-024-03284-x.
Sharma A, Kaiser PK, Tadayoni R, Holz FG, Nicholson L, Vazquez-Alfageme C, Sivaprasad S, Wakabayashi T, Woo SJ, Sarraf D, Kumar N, Parachuri N, Regillo CD, Rezaei KA, Khanani AM, Bandello F, Shanamugam M, Verma L, Dogra MR, Ns M, Agarwal M, Loewenstein A, Kuppermann BD, International Retina Biosimilar Study Group (Inter BIOS Group). Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond). 2024 Dec;38(17):3392–3395.

Published In

Eye (Lond)

DOI

EISSN

1476-5454

Publication Date

December 2024

Volume

38

Issue

17

Start / End Page

3392 / 3395

Location

England

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 3204 Immunology
  • 1113 Opthalmology and Optometry
  • 1107 Immunology
  • 1103 Clinical Sciences